Primary prostatic central zone adenocarcinoma

Pathology Research and Practice

Volumn 204, Issue 4, 2008, Pages 251-258

  Mai, Kien T ^a   Belanger, Eric C ^a   Al Maghrabi, Hatim M ^a   Robertson, Susan ^a   Wang, Don ^a   Margnean, Celia ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Adenocarcinoma; Central zone; Intraepithelial neoplasia; Prostate

Indexed keywords

ARTICLE; CANCER INCIDENCE; CELL NUCLEUS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIMARY PROSTATIC CENTRAL ZONE ADENOCARCINOMA; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SEMINAL VESICLE; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BIOPSY; CARCINOMA, DUCTAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 40849083587     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.11.002     Document Type: Article

References (30)

1. Amin M.B., and Bostwick D.G. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. Mod. Pathol. 9 (1996) 791-795
2. Arenas M.I., Romo E., de Gaspar I., de Bethencourt F.R., Sanchez-Chapado M., Fraile B., and Paniagua R. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. Glycoconj. J. 16 (1999) 338-375
3. Argani P., Walsh P.C., and Epstein J.I. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures: further evidence of the mesodermal origin of the prostatic central zone. J. Urol. 160 6, Part 1 (1998) 2126-2129
4. Bock B.J., and Bostwick D.G. Does prostatic ductal adenocarcinoma exist?. Am. J. Surg. Pathol. 23 (1999) 781-785
5. Brinker D.A., Potter S.R., and Epstein J.I. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am. J. Surg. Pathol. 2 29 (1999) 1471-1479
6. Chan P.S., Chan L.W., Xuan J.W., Chin J.L., Choi H.L., and Chan F.L. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate 41 (1999) 99-109
7. Cheng L., Jones T.D., Pan C.X., Barbarin A., Eble J.N., and Koch M.O. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod. Pathol. 18 (2005) 1022-10026
8. Colombel M., Vacherot F., Diez S.G., Fontaine E., Buttyan R., and Chopin D. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia. Br. J. Urol. 82 (1998) 380-385
9. Egevad L. Cytology of the central zone of the prostate. Diagn. Cytopathol. 28 (2003) 239-244
10. Herawi M., and Epstein J.I. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Am. J. Surg. Pathol. 31 30 (2007) 889-894
11. Kobayashi S., Tang R., Wang B., Opgenorth T., Stein E., Shapiro E., and Lepor H. Localization of endothelin receptors in the human prostate. J. Urol. 151 (1994) 763-766
12. Laczko I., Hudson D.L., Freeman A., Feneley M.R., and Masters J.R. Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kinetics. Prostate 62 (2005) 166-260
13. Leav I., Lau K.M., Adams J.Y., McNeal J.E., Taplin M.E., Wang J., Singh H., and Ho S.M. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159 (2001) 79-92
14. Lexander H., Franzen B., Hirschberg D., Becker S., Hellstrom M., Bergman T., Jornvall H., Auer G., and Egevad L. Differential protein expression in anatomical zones of the prostate. Proteomics 5 (2005) 2570-2576
15. Leung C.S., and Srigley J.R. Distribution of lipochrome pigment in the prostate gland: biological and diagnostic implications. Hum. Pathol. 26 (1995) 1302-1307
16. K.T. Mai. Personal Communication.
17. Mai K.T., Mokhtar G., Burns B.F., Perkins D.G., Yazdi H.M., and Stinson W.A. A simple technique for calculation of the volume of prostatic adenocarcinomas in radical prostatectomy specimens. Pathol. Res. Pract. 199 (2003) 599-604
18. McNeal J.E. The zonal anatomy of the prostate. Prostate 2 (1981) 35-49
19. McNeal J.E., Leav I., Alroy J., and Skutelsky E. Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. Am. J. Clin. Pathol. 89 (1988) 41-48
20. McNeal J.E. Normal histology of the prostate. Am. J. Surg. Pathol. 12 (1988) 619-633
21. McNeal J.E. Regional morphology and pathology of the prostate. Am. J. Clin. Pathol. 49 (1968) 347-357
22. McNeal J.E., Redwine E.A., Freiha F.S., and Stamey T.A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am. J. Surg. Pathol. 12 (1988) 897-906
23. Parsons J.K., Nelson C.P., Gage W.R., Nelson W.G., Kensler T.W., and De Marzo A.M. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. Prostate 49 (2001) 30-37
24. Reese J.H., McNeal J.E., Redwine E.A., Samloff I.M., and Stamey T.A. Differential distribution of pepsinogen II between the zones of the human prostate and the seminal vesicle. J. Urol. 136 (1986) 1148-1152
25. Reese J.H., McNeal J.E., Redwine E.A., Stamey T.A., and Freiha F.S. Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland. Prostate 12 (1988) 47-53
26. Reese J.H., McNeal J.E., Goldenberg S.L., Redwine E.A., and Sellers R.G. Distribution of lactoferrin in the normal and inflamed human prostate: an immunohistochemical study. Prostate 20 (1992) 73-85
27. Renshaw A.A., Richie J.P., Loughlin K.R., Jiroutek M., Chung A., and D'Amico A.V. Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients. Am. J. Clin. Pathol. 111 (1999) 641-644
28. Rubin M.A., de La Taille A., Bagiella E., Olsson C.A., and O'Toole K.M. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am. J. Surg. Pathol. 22 (1998) 840-848
29. Srodon M., and Epstein J.I. Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. Hum. Pathol. 33 (2002) 518-523
30. Tsurusaki T., Aoki D., Kanetake H., Inoue S., Muramatsu M., Hishikawa Y., and Koji T. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J. Clin. Endocrinol. Metab. 88 (2003) 1333-1340